Please login to the form below

Not currently logged in
Email:
Password:

INC Research appoints Clare Grace

She joins from PPD as VP site and patient access

Contract research organisation (CRO) INC Research has appointed Dr Clare Grace as VP of site and patient access.

In her new role, Grace will support INC Research's aim to create stronger connections with high performance clinical research sites and targeted patient populations.

She will also develop strategic relationships with patient advocacy and site management organisations, implement new approaches to work more effectively with sites and streamline operational functions to drive delivery quality and efficiency.

Grace joins from the CRO PPD where she held several leadership roles including senior director, head of global site intelligence and director of strategic site collaborations. Prior to PPD, she held clinical development roles within AstraZeneca and Antisoma.

Grace said of her new appointment: “Establishing more meaningful relationships with clinical research sites and patients is critical to our ability to deliver new medicines to market.

“We recognise that each trial and patient have specific needs and will work tirelessly to provide a personalised approach to meet these needs.”

Alistair Macdonald, chief operating officer, said: “INC Research understands the value sites bring to clinical research and is committed to enhancing our relationships with them to ultimately help bring new treatments to market more efficiently.

“We are very pleased to have Clare leading the team to execute on our vision of connecting at a deeper level with these key stakeholders and communities for mutually beneficial outcomes.”

3rd October 2014

From: Research

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics